Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer

NCT00669565 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma Breast Stage IV

Interventions

DRUG: Bavituximab

Sponsor

Peregrine Pharmaceuticals